![Francesca Domenech Wuttke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francesca Domenech Wuttke is the founder of Asten Biopharma Advisors, LLC, Nen Evidence Based Solutions SL.
Former jobs include Managing Director at Merck Global Health Innovation LLC, Managing Director at Merck Global Health Innovation Fund LLC, and Chief Digital Officer & Member-Management Board at Almirall SA from 2018 to 2019.
Education includes a doctorate from Weill Cornell Graduate School of Medical Sciences and an undergraduate degree from Cornell University College of Arts & Sciences.
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
Merck Global Health Innovation LLC
 Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health invests in companies located across the globe primarily in North America and Europe. The firm targets companies operating in the fields of drug discovery & clinical development, manufacturing, supply chain & IT, access to medicine & patient support and real world evidence generation It provides financing for early and growth stage capital requirements with an investment size of USD 5 - 10 million. | Private Equity Investor | 01/01/2019 |
Asten Biopharma Advisors, LLC | Fondateur | - |
Merck Global Health Innovation Fund LLC
 Merck Global Health Innovation Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Directeur Général | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Merck Global Health Innovation LLC
Merck Global Health Innovation LLC Investment ManagersFinance Merck Global Health invests in companies located across the globe primarily in North America and Europe. The firm targets companies operating in the fields of drug discovery & clinical development, manufacturing, supply chain & IT, access to medicine & patient support and real world evidence generation It provides financing for early and growth stage capital requirements with an investment size of USD 5 - 10 million. | Finance |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Weill Cornell Graduate School of Medical Sciences
 Weill Cornell Graduate School of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University College of Arts & Sciences
 Cornell University College of Arts & Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asten Biopharma Advisors, LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
